Wodsedalek DJ, Paddock SJ, Wan TC, Auchampach JA, Kenarsary A, Tsaih SW, Flister MJ, O'Meara CC. IL-13 promotes in vivo neonatal cardiomyocyte cell cycle activity and heart regeneration. There is great interest in identifying signaling mechanisms by which cardiomyocytes (CMs) can enter the cell cycle and promote endogenous cardiac repair. We have previously demonstrated that IL-13 stimulated cell cycle activity of neonatal CMs in vitro. However, the signaling events that occur downstream of IL-13 in CMs and the role of IL-13 in CM proliferation and regeneration in vivo have not been explored. Here, we tested the role of IL-13 in promoting neonatal CM cell cycle activity and heart regeneration in vivo and investigated the signaling pathway(s) downstream of IL-13 specifically in CMs. Compared with control, CMs from neonatal IL-13 knockout (IL-13 Ϫ/Ϫ ) mice showed decreased proliferative markers and coincident upregulation of the hypertrophic marker brain natriuretic peptide (Nppb) and increased CM nuclear size. After apical resection in anesthetized newborn mice, heart regeneration was significantly impaired in IL-13 Ϫ/Ϫ mice compared with wild-type mice. Administration of recombinant IL-13 reversed these phenotypes by increasing CM proliferation markers and decreasing Nppb expression. RNA sequencing on primary neonatal CMs treated with IL-13 revealed activation of gene networks regulated by ERK1/2 and Akt. Western blot confirmed strong phosphorylation of ERK1/2 and Akt in both neonatal and adult cultured CMs in response to IL-13. Our data demonstrated a role for endogenous IL-13 in neonatal CM cell cycle and heart regeneration. ERK1/2 and Akt signaling are important pathways known to promote CM proliferation and protect against apoptosis, respectively; thus, targeting IL-13 transmembrane receptor signaling or administering recombinant IL-13 may be therapeutic approaches for activating proregenerative and survival pathways in the heart.
INTRODUCTION
Although the majority of patients who endure a myocardial infarction (MI) survive the initial event, the physiological regeneration in the adult heart is grossly inadequate to compensate for the extensive loss of functional cardiomyocytes (CMs) (6, 28) . Once systolic heart failure occurs, current therapies delay but do not prevent progression to end-stage heart failure. Thus, there is a significant need to identify mechanisms by which we can stimulate endogenous heart regeneration in humans. Some lower organisms, such as zebrafish, newts, and neonatal mice, can fully regenerate their hearts after partial ablation through activation of endogenous pathways (17, 19, 30) . Genetic fate-mapping experiments have demonstrated that both zebrafish and neonatal mouse heart regeneration are facilitated by proliferation of preexisting CMs, with little apparent contribution from progenitor cell populations (17, 30) . Within the first week of life neonatal mouse CM proliferative capacity significantly decreases (30, 33) , correlating with a failure of the heart to regenerate. Although adult CMs are thought to be mostly senescent, there is evidence that some populations can indeed enter the cell cycle. A potentially promising mechanism to achieve heart repair in humans is reactivation of proliferation signaling programs in existing adult CMs. Activation of certain heart developmental pathways [e.g., Hippo/Yap (13, 37) , neuregulin 1 (Nrg1) (38) , and follistatin-like 1 (36) ] has proven to be a successful strategy for promoting postmitotic heart regeneration (4, 7, 39) , suggesting that insights into heart development and neonatal mammalian heart regeneration can provide clues as to how we can therapeutically achieve endogenous heart repair in the adult.
IL-13 is an anti-inflammatory cytokine that has been well characterized regarding its role in promoting polarization of macrophages toward an M2a alternatively activated phenotype (10, 40) . In addition to its well-established roles on immune cells, IL-13 directly acts on target tissues, such as lung smooth muscle cells (18) and skeletal muscle myoblasts (14) , to promote cell cycle activity during regenerative wound healing. The interaction between IL-13 and the myocardium during heart development and heart repair after injury has been vir-tually unexplored until recently. We recently used a top-down RNA-sequencing (RNAseq) transcriptomics approach to identify signaling factors that might mediate cardiac regeneration. This prior analysis identified IL-13 as a novel putative stimulus of CM cell cycle activity and cardiac regeneration. In vitro experiments demonstrated that recombinant (r)IL-13 treatment stimulated neonatal CM cell cycle activity, which was determined by increased CM bromodeoxyuridine (BrdU) incorporation, phosphorylated histone H3 (pH3) and Ki-67 expression, and increased CM cell numbers per well (28) . Subsequent studies reported that global deletion of IL-13 receptor-␣1 (IL-13R␣1) (1) or IL-13 cytokine (15) resulted in spontaneous heart failure and impaired post-MI recovery in adult mice, respectively, implicating a role for IL-13 signaling in not only the neonate but in adult heart function as well. IL-13 signals primarily through the type II receptor heterodimer consisting of IL-13R␣1 and IL4R␣ chains to activate STAT3 and STAT6, which are expressed on the surface of CMs, further suggesting a direct signaling interaction between IL-13 and CMs (1, 28) . These studies peripherally pointed to a novel role for direct stimulation of CMs by IL-13; however, the role of IL-13 in CM cell cycle activity in vivo or neonatal heart regeneration has not been well defined.
In the present study, we demonstrated that IL-13 knockout (IL-13 Ϫ/Ϫ ) mice exhibit decreased markers of CM cell cycle activity during early postnatal stages, suggesting a role for endogenous IL-13 during hyperplastic heart growth. Coincident with decreased CM proliferative markers, neonatal heart regeneration is impaired in IL-13 Ϫ/Ϫ mice compared with wild-type (WT) control mice. Administration of rIL-13 reversed several of the phenotypes observed in IL-13 Ϫ/Ϫ mice, specifically promoting CM cell cycle after neonatal heart injury and decreasing expression of the hypertrophic growth marker brain natriuretic peptide (Nppb). By RNAseq and Western blot analyses, we found that rIL-13 treatment promoted ERK1/2 and Akt activation in isolated CMs from both neonates and adults. The ERK1/2 and Akt pathways are known to be proproliferative and antiapoptotic in CMs, respectively (7) . Thus, targeting the IL-13 receptor or downstream mediators could provide a therapeutic approach for promoting CM proliferation and/or survival postinjury. Collectively, these data demonstrate a novel role for IL-13 in neonatal heart development and regeneration and elucidate molecular signaling events activated downstream of IL-13, specifically in CMs.
MATERIALS AND METHODS
Animals. Mice were housed in the Biomedical Resource Center at the Medical College of Wisconsin, an American Association for the Accreditation of Laboratory Animal Care-approved facility. All protocols used in this study were approved by the local Animal Care and Use Committee. Data were pooled from male and female mice for all in vivo experiments. IL-13 Ϫ/Ϫ mice were provided by Dr. Andrew McKenzie, and the generation of this strain has been previously reported (26) . IL-13 Ϫ/Ϫ mice were bred on a C57/BL6J genetic background, and C57/BL6J mice (referred to as WT) were purchased from Jackson Laboratories and used as controls.
Immunohistochemistry and histological quantification. Animals were euthanized by isoflurane administration followed by cervical dislocation. Hearts were washed in PBS and fixed in 4% paraformaldehyde, paraffin embedded, and sectioned at 4 m thickness before being stained. Deparaffinization was achieved by xylene treatment, and samples were rehydrated using an ethanol gradient (100%, 95%, and 70% followed by water). Antigen retrieval was achieved by boiling slides in 1ϫ DAKO citrate buffer, pH 6.0 (Agilent), for 20 min. Slides were blocked in 1% goat serum diluted in Tris-buffered saline with 0.5% Triton X-100. The primary antibodies used in this experiment are shown in Table 1 . Incubation with primary antibodies diluted 1:400 in blocking solution was done overnight at 4°C. The next day, slides were washed in PBS and incubated with goat ␣-mouse or goat ␣-rabbit secondary antibodies conjugated to Alexa Fluor 488 (A31620, goat polyclonal, Invitrogen) or Alexa Fluor 555 (A21429, goat polyclonal, Life Technologies) fluorophores for~1 h. DAPI (D1306, Invitrogen) staining was done directly before slides were mounted and imaged. Fluorescence was observed using either a Nikon Eclipse Ni-E microscope and imaged with a DS-Qi1 digital camera or an Eclipse 80i microscope and QIClick Mono 12-bit charge-coupled device camera. Nuclei were considered to be Mef2 positive if Ͼ80% of the area of the nucleus showed a positive signal. Nuclei with low levels of Mef2 staining were not considered Mef2 positive. For pH3/cardiac-type troponin T2 (cTnnt) and Mef2/proliferating cell nuclear antigen (PCNA) quantifications, six fields were collected from the left ventricle (LV) at ϫ20 magnification, and double-positive cells were counted by blinded and randomized analysis. Results are presented as average numbers of events per field. The distance between Mef2-positive nuclei was calculated using ImageJ by thresholding for Mef2-positive cells. Centroid coordinates for each nucleus were obtained through the Analyze Particles tool. The Nearest Neighbor Distance Image J plugin (https://icme.hpc.msstate.edu/mediawiki/ index.php/Nearest_Neighbor_Distances_Calculation_with_ImageJ) was used to calculate the distance in pixels from one nucleus centroid to the nearest neighboring nucleus centroid. The distances between nuclei for each image were averaged. For cell size quantification, heart sections were incubated with wheat germ agglutinin (WGA) conjugated to Alexa Fluor 594 (ThermoFisher Scientific) followed by DAPI stain. Two regions of each heart were imaged using a Nikon Eclipse Ni-E microscope and DS-Qi1 digital camera where the cross-sectional orientation of CMs was identified. Cell area was quantified in ImageJ by thresholding for the unstained cells surrounded by WGA stain. The Analyze Particles tool was used to quantify the area of thresholded cells.
RNA extraction and real-time PCR. RNA was extracted using TRIzol (Life Technologies) according to the manufacturer's instructions. Reverse transcription was performed with the High Capacity cDNA synthesis kit (Life Technologies) using up to 2 g RNA as starting material. SYBR Green PCR mix (Life Technologies) or Taqman PCR mix (Life Technologies) was used for quantitative Tables 1 and 2 .
Neonatal resection models. Neonatal mouse apical resection surgeries were performed as previously described (25) . Briefly, postnatal day 1 (P1) mice were anesthetized on ice for~3-4 min. A thoracotomy was performed, and the heart was retracted from the chest. Approximately 15% of the heart apex was resected, the heart was replaced, and the chest was sutured. Animals were recovered under a heat lamp until responsive to toe pinch and, once recovered, were returned to their mothers. Postoperative analgesic was withheld from animals because of confounding anti-inflammatory properties of nonsteroidal anti-inflammatory drugs and suppressive effects of opioids, which can increase maternal cannibalization of neonates. For IL-13 rescue experiments, rIL-13 (200 -400 ng/pup) or vehicle (PBS) was administered by subcutaneous injection the day after surgery and every other day until animals were euthanized for tissue collection at 7 days postresection.
Fibrosis and regeneration assessment at 21 days postresection. Apical resection was performed on WT or IL-13 Ϫ/Ϫ mice at P1, and hearts were collected at 21 days postresection. Whole hearts were fixed in 4% paraformaldehyde, paraffin embedded, and sectioned at 4 m thickness. Tissue sections were collected every 200 m through the heart to enable identification of the peak region of fibrosis. Sections from each plane were stained with Gomori's one-step trichome stain as previously described (9) . Trichrome-stained heart sections were scanned on a Nikon Super Coolscan 9000 (Nikon Instruments, Melville, NY) at a resolution of 4,000 dpi, and ϫ20 magnification of the fibrotic area was imaged on a Nikon E400 microscope with a SPOT Insight camera (Nikon Instruments). The area of apical fibrosis was quantified on 4,000 dpi scanned images by color threshold analysis using Metamorph software (Molecular Devices). Trichrome-stained and -scanned tissue sections from mice at 21 days postresection were subjected to regeneration scoring analysis, where a blinded observer assigned a score between 0 and 4 to each heart based on the degree of regeneration. The qualitative score designations were as follows: 0, complete regeneration (100%), with no apparent residual collagen detected at the resected apex; 1, nearly complete regeneration (Ͼ95%), with a small area of interstitial fibrosis present at the resected apex; 2, mostly regenerated (Ͼ75%), with a modest area of concentrated collagen present at the resected apex; 3, modest regeneration (Ͼ50%), with significant fibrotic scar remaining at the resected apex; and 4, failure to regenerate (Ͻ50%), where fibrotic scar has replaced the ventricular apex with little to no apparent remuscularization at the site of resection.
Echocardiography. Echocardiography was performed under light isoflurane anesthesia with spontaneous respiration. Echocardiography was performed using the VisualSonics Vevo 770 high-frequency ultrasound system. Short-axis two-dimensional images at the midpapillary levels of the LV were stored as digital loops. Three consecutive cardiac cycles were averaged. All echo data collection and analysis were performed in a blinded manner where the user was unaware of the treatment groups.
ELISA. Whole blood was collected at the time of euthanasia or by tail vein collection during time-course experiments and centrifuged for 5 min at 2,000 rpm, and the serum supernatant was transferred to a fresh tube. Serum IL-13 levels were quantified by sandwich ELISA using the Murine IL-13 Mini ABTS ELISA Development Kit (PeproTech, Rocky Hill, NJ) using 3,3=,5,5=-tetramethylbenzidine detection (eBioscience, San Diego, CA).
Isolation, culture, and treatment of ventricular neonatal rat and mouse CMs. Rat ventricular CMs were isolated from 1-to 2 -day-old Sprague-Dawley rats (Charles River). Neonatal rat hearts were dissociated in single cell suspension using the MACS Neonatal Heart Dissociation Kit (Miltenyi Biotec) according to the manufacturer's protocol. Red blood cell lysis step was not performed. Dissociated cells were neutralized with DMEM and 4.5 g/l glucose (Life Technologies) supplemented with 7.5% FBS and passed through a 70-m cell strainer. Dissociated cells were run through a Percoll gradient, the cell pellet containing purified CMs was washed with PBS, and CMs were plated in DMEM supplemented with 15% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin (Pen/Strep; Sigma) for~18 h. The following morning, medium was changed to serum-free DMEM supplemented with Pen/Strep. After 3 h of serum starvation, CMs were treated with 100 ng/ml murine rIL-13 (Peprotech). Cells were collected in lysis buffer for Western blot analysis at 20 min or 1 h after rIL-13 treatment. Mouse ventricular CMs were isolated from 1-to 2-day-old C57/BL6 mice using the same dissociation method as done for isolation of neonatal rat CMs. Instead of centrifuging cells through a Percoll gradient to purify CMs, dissociated cells were preplated for 1 h at 37°C to remove fibroblasts and endothelial cells, and nonadhered cells (primarily CMs) were collected and cultured for subsequent rIL-13 treatment experiments. For RNAseq experiments, cells were plated in DMEM containing 7.5% FBS for 24 h and then serum starved for 24 h followed by a 24-h exposure to 20 ng/ml murine rIL-13 (Peprotech). Cells were collected in 1 ml TRIzol for RNA extraction.
Isolation, culture, and treatment of adult rat CMs. Rat ventricular CMs were isolated from 6-to 8-wk-old Sprague-Dawley male rats (Charles River) according to a previously published protocol (41) . Isolated CMs were plated in DMEM and 4.5% glucose supplemented with 5% FBS and Pen/Strep and incubated at 37°C in 5% CO2 overnight. The following morning, medium was changed to serumfree DMEM, and 3 h postserum starvation, cells were treated with 100 ng/ml murine rIL-13 (Peprotech). Cells were collected in protein lysis buffer (as described below) for Western blot analysis.
RNAseq. For RNAseq experiments, neonatal rat CMs or cardiac fibroblasts were plated in DMEM supplemented with 15% FBS for 24 h followed by 24 h of serum starvation and then treated with murine rIL-13 (20 ng/ml, Peprotech) for 24 h. Untreated or rIL-13-treated CMs and cardiac fibroblasts were run in triplicate. mRNA was transcribed and chemically fragmented using Illumina's TruSeq RNA library kit. Indexed libraries were sequenced on an Illumina HiSeq 2500. The Trim Galore program (version 0.4.1) was used to trim bases with a phred quality score of Ͻ20 (https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/), and only reads with a phred quality score of Ն20 were taken for analysis. The RSEM program function "rsem-prepare-reference" (version 1.3.0) was used to extract the transcript sequences from the rat genome (build Rnor6.0) (21) and to generate Bowtie2 indexes (Bowtie2 version 2.2.8) (20) followed by read alignment using the "rsem-calculate-expression" function. Dif- Table 2 . List of SYBR Green primers used in the present study
Nppb, brain natriuretic peptide; Myh, myosin heavy chain; IL13Ra2, recombinant IL-13 receptor-␣2. Western blot analysis. Cultured cells were lysed in lysis buffer (200 mM NaCl, 20 mM Tris, 2 mM EDTA, 1% Triton X-100, and 0.1% SDS) supplemented with protease inhibitor cocktail (Sigma), PMSF (Sigma), phosphatase inhibitor cocktail 2 (Sigma), and phosphatase inhibitor cocktail 3 (Sigma). Cell debris was pelleted, and protein lysate supernatants were boiled with Laemmli buffer supplemented with ␤-mercaptoethanol. Membranes were blocked in 5% BSA in PBS with 0.1% Tween 20 or Tris-buffered saline with 0.1% Tween 20. Primary antibodies were incubated overnight at 4°C in 1% BSA in PBS with 0.1% Tween 20 or Tris-buffered saline with 0.1% Tween 20. Primary antibodies and dilutions used for Western blot analysis are shown in Table 1 . Membranes were washed and incubated for 1 h at room temperature in secondary antibody diluted 1:10,000 in 1% BSA in PBS with 0.1% Tween 20 or Tris-buffered saline with 0.1% Tween 20. Membranes were exposed with Pierce enhanced chemiluminescent blotting substrate (ThermoFisher) and imaged on a Bio-Rad ChemiDoc Imaging System.
Statistical analysis. Statistical analyses were performed using Sigma Plot 11.0 software. All data were analyzed by an unpaired two-tailed Student's t-test unless otherwise stated. All data are presented as means Ϯ SE unless otherwise indicated.
RESULTS
IL-13 genetic deletion results in decreased CM cell cycle markers during early postnatal development. We first tested whether IL-13 genetic deletion impacts CM phenotypes during neonatal development in the absence of cardiac injury. CM expression of cell cycle markers was assessed by histological analysis in hearts from 8-day-old unoperated WT and IL-13 Ϫ/Ϫ mice. Compared with WT mouse hearts, IL-13 Ϫ/Ϫ mouse hearts had a slight but insignificant decrease in pH3 staining, specifically in CMs, that was indicated by colocalization with cardiac troponin staining (Fig. 1A) . pH3 expression is restricted to metaphase (12) and marks a relatively short window of the cell cycle, prompting the examination of a second proliferative marker, PCNA (32) . We counterstained sections with the CM-specific nuclear marker Mef2 to distinguish CM nuclei from non-CM nuclei. The number of PCNA/Mef2 doublepositive nuclei was significantly decreased in IL-13 Ϫ/Ϫ compared with WT mouse hearts (24.73 Ϯ 2.52 vs. 40.8 Ϯ 5.15 cells/field, respectively; Fig. 1B ), suggesting a decrease in CM cell cycle activity. In addition, the incidence of sarcomere disassembly, which is observed during CM cell division and is increased during neonatal heart regeneration (30) , was also significantly decreased in IL-13 Ϫ/Ϫ compared with WT mice (1.62 Ϯ 0.37 vs. 2.04 Ϯ 0.29 cells/field, respectively; Fig. 1C ). At 3 wk of age, hearts from unoperated IL-13 Ϫ/Ϫ mice trended toward being smaller than WT mouse hearts ( Fig. 2A) , as assessed by echocardiography, although this difference did not reach statistical significance (P ϭ 0.066). Collectively, these data suggest that endogenous IL-13 contributes to the expression of CM cell cycle markers during early postnatal heart growth.
IL-13 Ϫ/Ϫ heart ventricles from neonatal mice had significantly increased expression of Nppb, a well-established marker of CM hypertrophic growth (34) . Elevated Nppb expression in IL-13 Ϫ/Ϫ mouse hearts was observed as early as 1 day of age ( Fig. 1D ), suggesting that IL-13 signaling contributes to heart growth during embryonic or early postnatal development. In contrast, no differences in expression patterns of myosin heavy chain (Myh)6 or Myh7 were observed, demonstrating that the myosin isoform maturation is not affected by IL-13 signaling. Enlarged CM nuclei is associated with CM hypertrophy (11), and we observed that the cross-sectional area of Mef2 ϩ CM nuclei was significantly increased in 8-day-old IL-13 Ϫ/Ϫ compared with WT mouse hearts (Fig. 1E ). We next measured distances between Mef2-positive nuclei in P8 WT and IL-13 Ϫ/Ϫ mice as a means to estimate cell size, since neonatal cellular organization makes reliable WGA staining and crosssectional area quantification difficult. Indeed, we found that IL-13 Ϫ/Ϫ mice had significantly increased distances between Mef2-positive nuclei, suggesting cardiac cell hypertrophy (Fig.  1F) . Overall, heart weights at 8 days of age were not different between WT and IL-13 Ϫ/Ϫ mice, likely because of compensatory cell hypertrophy in response to decreased CM cell cycle activity (Fig. 1G) . These data suggest that genetic deletion of IL-13 decreases CM hyperplastic growth during developmental stages and increases markers of hypertrophic growth.
Neonatal heart regeneration is impaired in IL-13 knockout mice. We hypothesized that suppressed CM cell cycle activity would impact neonatal heart regeneration in IL-13 Ϫ/Ϫ mice. To test this hypothesis, apical resection injury was performed on P1 IL-13 Ϫ/Ϫ and WT mice followed by functional and histological assessment of heart regeneration. At 21 days postresection, echocardiography revealed that IL-13 Ϫ/Ϫ mice had significantly increased LV internal diameters during both diastole and systole, whereas fractional shortening and ejection fraction showed a decreasing trend in IL-13 Ϫ/Ϫ mice that did not reach statistical significance ( Fig. 2A) . Unoperated WT and IL-13 Ϫ/Ϫ mice showed no difference in LV internal diameter during diastole, LV internal diameter during systole, fractional shortening, or ejection fraction, suggesting that no baseline functional differences in WT and IL-13 Ϫ/Ϫ hearts were expected to affect postinjury response. Hearts were collected at 21 days postresection, formalin fixed, and paraffin embedded for histological analysis of regeneration. Compared with fully regenerated WT hearts, limited tissue regeneration and increased LV dilation were observed in IL-13 Ϫ/Ϫ hearts (Fig. 2B) . To quantify the differences in the regenerative capacity between WT and IL-13 Ϫ/Ϫ hearts, a regeneration score of 0 -4 was assigned to each heart by a blinded observer, with 0 indicating complete regeneration and 4 indicating no regeneration. This analysis revealed a significantly worse regeneration score in IL-13 Ϫ/Ϫ hearts (median score: 3) compared with WT hearts (median score: 1, P ϭ 0.032). IL-13 Ϫ/Ϫ hearts also had a significantly increased area of apical fibrosis as quantified by morphometric color threshold analysis of trichrome staining (Fig. 2, C and D) . Histological sections from resected hearts collected 21 days postresection were stained with WGA to identify cell membranes ( Fig. 2E ). Morphometric quantification of WGA-stained sections revealed that the myocyte cross-sectional area was significantly increased in IL-13 Ϫ/Ϫ hearts, suggesting cell hypertrophy (Fig. 2F) . Thus, IL-13 Ϫ/Ϫ hearts fail to regenerate and instead develop LV dilation and cardiac cell hypertrophy, suggesting that IL-13 is a critical proregenerative signal in the neonatal heart. 
rIL-13 administration enhances markers of the CM cell cycle and decreases hypertrophic gene expression in IL-13
Ϫ/Ϫ mice. Because global deletion of IL-13 resulted in decreased markers of CM proliferation, we hypothesized that administration of rIL-13 would enhance markers of CM proliferation phenotypes in IL-13 Ϫ/Ϫ mice. We first assessed the half-life of circulating IL-13 in adult mice to determine the required frequency of rIL-13 injections for our experiments. We in-jected 100 ng rIL-13 in 8-to 10-wk-old WT mice by intraperitoneal injection and collected serum samples for IL-13 quantification by ELISA at baseline and 4, 8, 24, and 48 h after injection. After the rIL-13 injection, circulating IL-13 levels peaked at~4 h postinjection and remained slightly elevated by 24 and 48 h postinjection (Fig. 3A) . Based on these circulating levels of IL-13 after injection, we injected animals with rIL-13 every 48 h for the duration of the in vivo experiments. We performed apical resection on P1 IL-13 Ϫ/Ϫ mice and injected animals with 0.5 mg/kg rIL-13 or vehicle (PBS) by subcutaneous injection at 1, 3, 5, and 7 days after surgery and collected hearts and serum~4 h after the final injection (Fig. 3B ). Serum levels of IL-13 were elevated to~125 Ϯ 8.77 pg/ml in rIL-13treated neonates at the time of tissue collection, whereas vehicle-injected animals had nearly undetectable levels of circulating IL-13 (Fig. 3C) . Quantitative PCR analysis of known downstream transcriptional target of IL-13 [arginase 1 (Arg1)] (35) and the soluble IL-13 decoy receptor (IL-13R␣2) (8) were significantly elevated in hearts of unoperated animals injected with rIL-13, demonstrating the bioactivity of the cytokine in heart tissue (Fig. 3D ). In addition, rIL-13 treatment significantly decreased LV expression of the hypertrophic marker Nppb in unoperated animals, whereas Myh6 and Myh7 were unchanged (Fig. 3E ). Histological analysis revealed that rIL-13 treatment significantly increased the number of pH3positive CMs by~28.0% compared with littermate controls at 7 days postresection (Fig. 3F) . PCNA/Mef2 double-positive cells were also significantly increased by~25.3% in mice injected with rIL-13 compared with vehicle ( Fig. 3G) . Cells that were troponin negative but pH3 positive also were slightly but insignificantly increased after rIL-13 administration. Although this difference did not reach statistical significance, it is possible that IL-13 could act on other cell types besides CMs in the heart (Fig. 3H ). We next tested whether, as in IL-13 Ϫ/Ϫ mice, administration of rIL-13 to WT mice also promoted CM cell cycle activity after injury. We performed apical resection on P1 WT mice, injected rIL-13 every other day, and collected hearts at 7 days postresection, as shown in Fig. 3B . In contrast with IL-13 Ϫ/Ϫ mice, administration of rIL-13 did not increase pH3 ϩ /cTnnt ϩ cells. rIL-13 administration to WT mice tended to decrease pH3 ϩ /cTnnt ϩ cells, although this did not reach statistical significance (Fig. 3I ). Together, these data demonstrate that rIL-13 administration can reverse the CM cell cycle activity phenotype in neonatal IL-13 Ϫ/Ϫ mouse hearts in vivo but does not appear to increase CM cell cycle activity on the WT background after neonatal injury.
IL-13 promotes ERK and Akt gene signaling networks in neonatal cardiomyocytes. IL-13 is known to act through the IL-13R␣1/IL4R␣ heterodimer to promote STAT6 and STAT3 phosphorylation (5) in neonatal CMs in response to IL-13 treatment (28), yet the collective downstream molecular networks that are activated in IL-13-stimulated CMs remain unexplored. To begin exploring the IL-13-dependent gene networks in CMs, cultured neonatal rat CMs were treated with 20 ng/ml rIL-13 for 24 h and then analyzed by RNAseq. Detection of high levels of CM-specific transcripts (Nppa, Nppb, Myh6, and Myh7) and low expression of fibroblastspecific transcripts [periostin (Postn), collagen (Col)3a1, fibrillin-1 (Fbn1), and elastin (Eln)] indicated a highly purified CM population compared with isolated fibroblasts from the same cell preparation. Compared with control CMs, 351 differentially expressed genes (false discovery rate Ͻ 0.05) were detected in CMs that were stimulated by rIL-13 treatment (see Table S1 in the Supplemental Material; Supplemental Material for this article is available at the American Journal of Physiology-Heart and Circulatory Physiology website).
The molecular gene networks that were altered in rIL-13stimulated CMs were analyzed using the IPA tool. Compared with nontreated CMs, rIL-13 promoted activation of ERK signaling, the IL-1 cellular response, and cell migration biological processes, among others. On the other hand, NF-B, endocytosis, and inflammatory response were among the processes most significantly downregulated upon rIL-13 treatment (Fig. 4A) , reflecting the anti-inflammatory properties of IL-13 (16) . We next used IPA to identify the putative upstream regulators of differentially expressed gene networks in CMs treated with rIL-13 compared with nontreated cells to identify regulatory signaling nodes. Predicted upstream regulators of differentially expressed gene networks that were most highly activated included IL-13, STAT6, and STAT3, as we would expect based on the experimental design and known mediators of IL-13 signaling (Fig. 4B) . Of interest, we found that ERK1/2 and phosphatidylinositol 3-kinase signaling groups were predicted to be top regulators of differentially expressed gene networks (Fig. 4C ). ERK1/2 and Akt signaling are important regulators of CM cell cycle activity and prosurvival pathways, and these have been shown to be activated in response to proheart regenerative molecules such as Nrg1 (7) and agrin (2). Fig. 3 . Recombinant IL-13 (rIL-13) administration promotes cardiomyocyte (CM) cell cycle activity and inhibits hypertrophic gene expression in IL-13 Ϫ/Ϫ mice. A: adult mice injected with rIL-13 (100 ng) followed by quantification of serum IL-13 levels by ELISA for 48 h after injection (n ϭ 3). B: experimental outline. Apical resection (or no operation in the case of quantitative PCR data shown in D and E) was performed on postnatal day 1 (P1) IL-13 Ϫ/Ϫ mice, and animals were injected every other day with rIL-13 or vehicle until 7 days postresection, when tissues were collected for analysis. C: serum levels of IL-13 4 h after subcutaneous IL-13 injection in a P8 mouse (n ϭ 4/group). D: quantitative PCR quantification of soluble IL-13 decoy receptor (IL-13R␣2) and arginase 1 (Arg1) expression in P8 heart ventricular tissue from unoperated animals injected with rIL-13 every other day (n ϭ 8/group). G: quantitative PCR analysis of CM-specific hypertrophic gene expression in unoperated P8 heart ventricles (n ϭ 11/ group). F-H: histological quantification of phosphorylated histone H3 (pH3) ϩ /cardiactype troponin T2 (cTnnt ϩ ) cells (F), proliferating cell nuclear antigen (PCNA) ϩ / Mef2C ϩ cells (G), or pH3 ϩ /cTnnt Ϫ cells/ field from IL-13 Ϫ/Ϫ hearts (H) resected at P1 and collected 7 days postresection. Animals were injected with either vehicle (PBS) or rIL-13 as shown in B. n ϭ 9/group. I: histological quantification of pH3 ϩ /cTnnt ϩ cells/ field from wild-type (WT) mouse hearts at 7 days postresection. Mouse hearts were resected at P1 followed by vehicle or rIL-13 administration as described in B. n ϭ 5/group. Data in F-I are presented as a percentage of control, which indicates each sample was normalized to littermate controls, since histological observance and staining intensity can vary from litter to litter. AR, apical resection; WRT, with respect to. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001.
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ROLE OF IL-13 IN NEONATAL HEART REGENERATION
To confirm the upstream regulator predictions from our RNAseq analysis, we cultured neonatal rat CMs and assessed protein phosphorylation by Western blot analysis after rIL-13 treatment. Both Akt and ERK1/2 were robustly phosphorylated shortly after rIL-13 treatment, and both were dephosphorylated by 1 h posttreatment ( Fig. 5 ). IL-13 receptors have been reported to be expressed on adult CMs, so we next tested whether adult CMs also activate ERK1/2 and Akt in response to IL-13. Similar to neonates, we observed a robust phosphorylation of both ERK1/2 and Akt after rIL-13 stimulation in adult cultured CMs (Fig. 5 ). We repeated this experiment using neonatal mouse CMs to test if, as in the rat, rIL-13 also promotes ERK1/2 and Akt phosphorylation in the mouse. Both Akt and ERK1/2 were rapidly phosphorylated in mouse CMs in response to rIL-13 treatment (Fig. 5) , demonstrating that IL-13 signaling is, at least in part, conserved in mice and rats. Reactivating adult CM proliferation is a potential strategy for inducing cardiac regeneration in humans, and these data suggest that proproliferative and antiapoptotic pathways can be activated in adult CMs after exposure to rIL-13.
DISCUSSION
Our findings strongly suggest a role for endogenous IL-13 in mouse CM cell cycle activity during early postnatal development and heart regeneration and shed light on the downstream signaling events that potentially mediate IL-13 signaling, specifically in CMs. Interestingly, not only were markers of CM cell cycle decreased in unoperated IL-13 Ϫ/Ϫ mice at 8 days of age, but we also found evidence of increased CM hypertrophy in these mice. In mammals, CM proliferation peaks during embryonic development and rapidly declines shortly after birth. Subsequent heart growth is achieved primarily by CM hypertrophy, whereas the rate of CM renewal in both adult mouse and humans is estimated at only~1%/yr (3, 33) . In the absence of a proproliferative cytokine, such as IL-13 during fetal and early postnatal development, when CMs are normally highly proliferative, compensatory hypertrophic growth programs may be enhanced, as indicted by Nppb expression, increased CM nuclear size, and increased cardiac cell size. Although we did not observe overt LV functional differences Fig. 4 . Recombinant IL-13 activates ERK and Akt signaling gene networks in neonatal rat cultured cardiomyocytes (CMs). A: top 5 Database for Annotation, Visualization and Integrated Discovery biological processes ontological terms for genes significantly upregulated or downregulated in response to rIL-13 treatment in neonatal rat CMs. B: top "cytokine," "transcription regulator," or "group" upstream regulators predicted by Ingenuity Pathway Analysis (IPA) of all differentially expressed genes in CMs after rIL-13 treatment. C: heat map of genes that fall under ERK-or Aktregulated networks from IPA. in the unoperated juvenile IL-13 Ϫ/Ϫ mice, a recent study (1) demonstrated that, by 22 wk of age, global deletion of IL-13R␣1 resulted in spontaneous LV dilation, reduced ejection fraction, and reduced radial strain. Thus, the IL-13 signaling axis appears to influence normal heart development and ventricular function in the absence of injury. Coincident with decreased markers of cell cycle activity, we observed significantly larger CM nuclei and increased distance between CM nuclei in unoperated IL-13 Ϫ/Ϫ mice compared with WT mice. Emerging evidence indicates that the DNA content in CMs influences their ability to enter the cell cycle, specifically, binucleated or polyploid CMs have a lower propensity to divide (29) . It is possible that increased nuclear size in IL-13 Ϫ/Ϫ mice is indicative of increased DNA content, potentially influencing regenerative potential. In addition, increased distance between Mef2 nuclei could indicate increased cell size, as we presumed, or alternatively could indicate decreased nucleation per cell. Future experiments will be aimed to quantifying ploidy and nucleation status in IL-13 Ϫ/Ϫ mice. To our knowledge, IL-13 has not previously been attributed to CM hyperplastic growth during the fetal or early postnatal development stages.
We further demonstrated that IL-13 Ϫ/Ϫ neonatal mice failed to fully regenerate their hearts in response to apical resection injury. The underlying lack of CM cell cycle marker expression during development likely contributes to the impaired regenerative capacity in IL-13 Ϫ/Ϫ neonatal mice. However, we cannot exclude the possibility that IL-13 signaling on non-CMs, such as fibroblasts or immune cells, might indirectly contribute to the regenerative response. Recent work demonstrated that, in zebrafish, fibroblast activation and collagen production promoted CM proliferation during cardiac regeneration (31) . In addition, depletion of regulatory T cells significantly diminishes CM proliferation in pregnant and fetal mice and impairs post-MI healing (42) . IL-13 is well known to be secreted by T cells, so immune modulation by IL-13 could contribute to the impaired heart regeneration phenotype in IL-13 Ϫ/Ϫ mice. Thus, the complex interaction between CMs and their environment likely determines their overall proliferative capacity. IL-13 is known to act on various cell types, including fibroblasts and immune cells. Cell type-specific receptor deletion experiments are therefore required to further elucidate the mechanistic role of IL-13 in heart regeneration.
Although pleiotropic actions of IL-13 may contribute to regeneration phenotypes in IL-13 Ϫ/Ϫ mice, a previous study has demonstrated that the IL-13 receptors are expressed on the surface of CMs (1), and our work shows that IL-13 does indeed signal directly in cultured CMs. Thus, direct stimulation of CMs by IL-13 likely contributes, at least in part, to CM cell cycle and heart regeneration in vivo. rIL-13 administration significantly increased CM cell cycle markers in IL-13 Ϫ/Ϫ mice; however, we unexpectedly found that, after resection in WT mice, rIL-13 administration did not increase but rather showed a trend toward decreasing pH3 expression. We postulate that rIL-13 administration might have a modified effect when delivered to CMs that are robustly proliferating (as in WT mice at 7 days postresection) compared with CMs that are undergoing low levels of cell cycle activity (as in IL-13 Ϫ/Ϫ mice or cultured CMs). Further experiments are warranted to test this hypothesis. We aimed to begin elucidating the downstream signaling factors that might mediate the proproliferative effects of IL-13 signaling in cultured CMs. IL-13 typically signals through the IL-13R␣1/IL4R␣ heterodimer to activate STAT3 and STAT6 phosphorylation and downstream signaling events. However, noncanonical IL-13 signaling, including ERK activation, has also been reported in certain cell types (27) , and the collective signaling events downstream of IL-13 in CMs are largely unknown. We used RNAseq as an unbiased approach to begin to identify downstream pathways activated in CMs in response to IL-13, and, in addition to STAT6 and STAT3, we found ERK and phosphatidylinositol 3-kinase to be prominent upstream regulators of differentially expressed gene networks after rIL-13 treatment. Likewise, rIL-13 treatment strongly stimulates ERK1/2 and Akt phosphorylation in cultured CMs from both rats and mice. Several studies have pointed to a role of ERK1/2 and Akt activation in CM proliferation and antiapoptotic phenotypes. For example, Nrg1 is well known to be required for heart development, and several studies have reported a role for Nrg1 administration and overexpression of the Nrg1 receptor Erbb2 in promoting postnatal CM proliferation and heart regeneration (7) . Proproliferative and antiapoptotic effects of Nrg1 have been reported to be mediated through ERK1/2 and Akt activation in CMs, respectively (22) . In addition, the proheart regenerative matrix molecule agrin promotes CM proliferation through activation of ERK1/2 signaling in cultured CMs (2) , and the MAPK/ERK pathway is required for cardiac regeneration in the proregenerative zebrafish model (23) . Collectively, accumulating evidence has demonstrated that ERK and Akt signaling pathways are critical mediators of CM proliferation and survival across species, and our data demonstrate that IL-13 activates these common pathways in not only neonatal CMs but also in adult CMs. Identifying mechanisms by which we can reactivate ERK and Akt signaling, and possibly other ancillary pathways, in adult CMs may provide a therapeutic approach for stimulating CM survival or even endogenous heart regeneration postinjury.
Our work points to a direct signaling role of IL-13 on CMs; however, we cannot exclude the possibility that IL-13 signals on other cell types, such as macrophages or fibroblasts, which indirectly promote CM proliferation and heart regeneration in vivo. In future studies, we aim to investigate cell type-specific modulation of IL-13 receptors to better understand the physiological consequence of rIL-13 administration on heart regeneration and repair after injury. Additional experiments are required to understand IL-13 signaling in the myocardium at different developmental stages, including adults, and perhaps on different genetic backgrounds. Understanding the factors that promote CM proliferation and heart regeneration during the developmental window will shed light on mechanisms that can be reactivated to promote heart regeneration in the adult.
